Cas no 88915-26-8 ((1-Benzylpiperidin-4-yl)methanamine)

(1-Benzylpiperidin-4-yl)methanamine structure
88915-26-8 structure
Product Name:(1-Benzylpiperidin-4-yl)methanamine
CAS No:88915-26-8
MF:C13H20N2
MW:204.311303138733
MDL:MFCD04116211
CID:61212
PubChem ID:1514444
Update Time:2024-10-26

(1-Benzylpiperidin-4-yl)methanamine Chemical and Physical Properties

Names and Identifiers

    • (1-Benzyl-4-piperidinyl)methylamine
    • (1-benzylpiperidin-4-yl)methanamine
    • [(1-Benzylpiperidin-4-yl)methyl]amine
    • 1-benzyl-piperidin-4-methylamine
    • 4-AMINOMETHYL-1-BENZYLPIPERIDINE HCL
    • 1-(1-benzylpiperidin-4-yl)methanamine(SALTDATA: FREE)
    • 4-aminomethyl-1-benzylpiperidine
    • (1-Benzyl-4-piperidyl)methylamine
    • 1-Benzyl-4-piperidinemethanamine
    • 1-Phenylmethyl-4-piperidinemethanamine
    • 4-(Aminomethyl)-1-(phenylmethyl)piperidine
    • 1-(Phenylmethyl)-4-piperidinemethanamine (ACI)
    • (1-Benzylpiperidin-4-yl)methylamine
    • 1-(1-Benzylpiperidin-4-yl)methanamine
    • AKOS000210617
    • KNUKUWNSGVICSX-UHFFFAOYSA-N
    • 4-piperidinemethanamine, 1-(phenylmethyl)-
    • c-(1-benzyl-piperidin-4-yl)-methylamine
    • ALBB-005762
    • EN300-54071
    • MFCD04116211
    • 1-(phenylmethyl)4-piperidinemethanamine
    • 1-(phenylmethyl)-4-piperidinemethanamine
    • DTXSID70363891
    • DB-011669
    • (1-benzyl-4-piperidyl)methanamine
    • 4-Aminomethyl-1-benzyl piperdine
    • J-504321
    • SY078079
    • 88915-26-8
    • DS-1519
    • FS-2025
    • 4-aminomethyl-1-phenylmethyl piperidine
    • CS-0122586
    • SB44044
    • C-(1-Benzylpiperidin-4-yl)methylamine
    • STK347048
    • BBL038077
    • Z326203048
    • SCHEMBL1061878
    • 1-benzyl-4-aminomethylpiperidine
    • 1-(1-Benzyl-4-piperidinyl)methanamine
    • 1-Benzylpiperidine-4-methanamine
    • (1-Benzylpiperidin-4-yl)methanamine
    • MDL: MFCD04116211
    • Inchi: 1S/C13H20N2/c14-10-12-6-8-15(9-7-12)11-13-4-2-1-3-5-13/h1-5,12H,6-11,14H2
    • InChI Key: KNUKUWNSGVICSX-UHFFFAOYSA-N
    • SMILES: NCC1CCN(CC2C=CC=CC=2)CC1

Computed Properties

  • Exact Mass: 204.16300
  • Monoisotopic Mass: 204.163
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 2
  • Heavy Atom Count: 15
  • Rotatable Bond Count: 3
  • Complexity: 167
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 29.3A^2
  • XLogP3: 1.6

Experimental Properties

  • Boiling Point: 125 oC (1 mmHg)
  • Flash Point: 126.4°C
  • PSA: 29.26000
  • LogP: 2.49550

(1-Benzylpiperidin-4-yl)methanamine Security Information

  • Hazardous Material transportation number:UN 3261
  • Hazard Category Code: R21/22;R34
  • Safety Instruction: S23-S26-S36/37/39-S45
  • Hazardous Material Identification: C
  • HazardClass:IRRITANT
  • Risk Phrases:R21/22; R34

(1-Benzylpiperidin-4-yl)methanamine Customs Data

  • HS CODE:2933399090
  • Customs Data:

    China Customs Code:

    2933399090

    Overview:

    2933399090. Other compounds with non fused pyridine rings in structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

    Declaration elements:

    Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date

    Summary:

    2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

(1-Benzylpiperidin-4-yl)methanamine Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Chemenu
CM179381-25g
[(1-Benzylpiperidin-4-yl)methyl]amine
88915-26-8 95%
25g
$337 2021-08-05
TRC
B288965-10mg
(1-Benzylpiperidin-4-yl)methanamine
88915-26-8
10mg
$ 50.00 2022-06-07
TRC
B288965-50mg
(1-Benzylpiperidin-4-yl)methanamine
88915-26-8
50mg
$ 65.00 2022-06-07
TRC
B288965-100mg
(1-Benzylpiperidin-4-yl)methanamine
88915-26-8
100mg
$ 80.00 2022-06-07
Fluorochem
032680-1g
C-(1-Benzyl-piperidin-4-yl)-methylamine
88915-26-8 95%
1g
£29.00 2022-03-01
Fluorochem
032680-5g
C-(1-Benzyl-piperidin-4-yl)-methylamine
88915-26-8 95%
5g
£85.00 2022-03-01
Fluorochem
032680-10g
C-(1-Benzyl-piperidin-4-yl)-methylamine
88915-26-8 95%
10g
£142.00 2022-03-01
Fluorochem
032680-25g
C-(1-Benzyl-piperidin-4-yl)-methylamine
88915-26-8 95%
25g
£282.00 2022-03-01
Alichem
A129004738-10g
(1-Benzylpiperidin-4-yl)methanamine
88915-26-8 95%
10g
$205.80 2023-08-31
Alichem
A129004738-25g
(1-Benzylpiperidin-4-yl)methanamine
88915-26-8 95%
25g
$352.80 2023-08-31

(1-Benzylpiperidin-4-yl)methanamine Production Method

Production Method 1

Reaction Conditions
1.1 Reagents: Lithium aluminum hydride Solvents: Diethyl ether ;  0 °C → rt; overnight, rt
Reference
New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition
Estrada, Martin; Perez, Concepcion; Soriano, Elena; Laurini, Erik; Romano, Maurizio; et al, Future Medicinal Chemistry, 2016, 8(11), 1191-1207

Production Method 2

Reaction Conditions
1.1 Reagents: Lithium aluminum hydride Solvents: Tetrahydrofuran ;  0 °C; 6 h, reflux; reflux → rt
1.2 Reagents: Water ;  15 min, 0 °C
1.3 Reagents: Sodium hydroxide Solvents: Water ;  15 min, 0 °C
Reference
Synthesis and Evaluation of Multi-Target-Directed Ligands against Alzheimer's Disease Based on the Fusion of Donepezil and Ebselen
Luo, Zonghua; Sheng, Jianfei; Sun, Yang; Lu, Chuanjun; Yan, Jun; et al, Journal of Medicinal Chemistry, 2013, 56(22), 9089-9099

Production Method 3

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Ethanol ;  90 °C
1.2 Reagents: Lithium aluminum hydride Solvents: Dichloromethane ,  Tetrahydrofuran ;  70 °C
Reference
Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease
de Andrade, Peterson; Mantoani, Susimaire P.; Goncalves Nunes, Paulo Sergio; Magadan, Carlos Roca; Perez, Concepcion; et al, Bioorganic & Medicinal Chemistry, 2019, 27(6), 931-943

Production Method 4

Reaction Conditions
1.1 Reagents: Hydrochloric acid Solvents: 1,4-Dioxane ;  2 h, rt
Reference
Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonists
Adlere, I.; Sun, S.; Zarca, A.; Roumen, L.; Gozelle, M.; et al, European Journal of Medicinal Chemistry, 2019, 162, 631-649

Production Method 5

Reaction Conditions
1.1 Reagents: Lithium aluminum hydride Solvents: Tetrahydrofuran ;  2 h, rt → reflux
Reference
The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity
Kosak, Urban; Brus, Boris; Knez, Damijan; Zakelj, Simon; Trontelj, Jurij; et al, Journal of Medicinal Chemistry, 2018, 61(1), 119-139

Production Method 6

Reaction Conditions
1.1 Reagents: Acetic acid ,  Sodium triacetoxyborohydride Solvents: 1,2-Dichloroethane ;  30 min, rt; 16 h, rt
1.2 Reagents: Hydrochloric acid Solvents: Water ;  pH 1, rt
Reference
Design, synthesis, and characterization of novel, nonquaternary reactivators of GF-inhibited human acetylcholinesterase
McHardy, Stanton F.; Bohmann, Jonathan A.; Corbett, Michael R.; Campos, Bismarck ; Tidwell, Michael W.; et al, Bioorganic & Medicinal Chemistry Letters, 2014, 24(7), 1711-1714

Production Method 7

Reaction Conditions
1.1 Reagents: Lithium aluminum hydride Solvents: Diethyl ether
1.2 Solvents: Water
Reference
Aminopyridazines as acetylcholinesterase inhibitors
Contreras, Jean-Marie; Rival, Yveline M.; Chayer, Said; Bourguignon, Jean-Jacques; Wermuth, Camille G., Journal of Medicinal Chemistry, 1999, 42(4), 730-741

Production Method 8

Reaction Conditions
1.1 Reagents: Lithium aluminum hydride Solvents: Tetrahydrofuran
Reference
Synthesis of Novel Galanthamine Analog Acetylcholinesterase Inhibitors via Tandem Cyclization
Treu, Matthias, 2000, , ,

Production Method 9

Reaction Conditions
1.1 Reagents: Lithium aluminum hydride Solvents: Tetrahydrofuran ;  4 °C; 30 min, rt
1.2 Reagents: Water ;  cooled
Reference
Design, synthesis, and biological evaluation of novel N-Benzyl piperidine derivatives as potent HDAC/AChE inhibitors for Alzheimer's disease
Qin, Pengxia; Ran, Yingying; Xie, Fei; Liu, Yujing; Wei, Chao; et al, Bioorganic & Medicinal Chemistry, 2023, 80,

Production Method 10

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Ethanol ;  16 h, reflux
1.2 Reagents: Lithium aluminum hydride Solvents: Tetrahydrofuran ;  6 h, reflux
Reference
Synthesis of novel substituted pyrimidine derivatives bearing a sulfamide group and their in vitro cancer growth inhibition activity
Lefebvre, Carole-Anne; Forcellini, Elsa; Boutin, Sophie; Cote, Marie-France; C.-Gaudreault, Rene; et al, Bioorganic & Medicinal Chemistry Letters, 2017, 27(2), 299-302

Production Method 11

Reaction Conditions
1.1 Reagents: Lithium aluminum hydride Solvents: Tetrahydrofuran ;  rt; 6 h, reflux
Reference
Synthesis of isocyanides through dehydration of formamides using XtalFluor-E
Keita, Massaba; Vandamme, Mathilde; Mahe, Olivier; Paquin, Jean-Francois, Tetrahedron Letters, 2015, 56(2), 461-464

Production Method 12

Reaction Conditions
1.1 Reagents: Lithium aluminum hydride Solvents: Tetrahydrofuran ;  0 °C; 16 h, reflux; reflux → 0 °C
1.2 Reagents: Sodium hydroxide Solvents: Water ;  0 °C; 10 min, 0 °C
Reference
Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer's Disease
Mao, Fei; Wang, Huan; Ni, Wei; Zheng, Xinyu; Wang, Manjiong; et al, ACS Chemical Neuroscience, 2018, 9(2), 328-345

Production Method 13

Reaction Conditions
1.1 Reagents: Lithium aluminum hydride Solvents: Tetrahydrofuran ;  reflux
Reference
Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease
Shao, Dong; Zou, Chunyan; Luo, Cheng; Tang, Xican; Li, Yuanchao, Bioorganic & Medicinal Chemistry Letters, 2004, 14(18), 4639-4642

(1-Benzylpiperidin-4-yl)methanamine Raw materials

(1-Benzylpiperidin-4-yl)methanamine Preparation Products

Recommended suppliers
Zhejiang Brunova Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Zhejiang Brunova Technology Co., Ltd.
Xiamen PinR Bio-tech Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Xiamen PinR Bio-tech Co., Ltd.
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Shandong Feiyang Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Feiyang Chemical Co., Ltd